DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
Q4 2022 13F-HR Holdings
Net value change ($000)
-192,732
(-3.8%)
New positions
13
Sold out positions
33
Turnover %
39.3%
Sector allocation + QoQ delta (equities-only)
Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown
Snapshot: Change Analysis
Compared to Q3 2022
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| NUVL | 219,343 | 58.3% |
| SRPT | 165,398 | NEW |
| AMLX | 99,506 | NEW |
| SPRY | 94,495 | NEW |
| ADY | 60,086 | 172.6% |
| CPRX | 46,635 | 74.2% |
| PCVX | 33,565 | NEW |
| NAMS | 27,034 | NEW |
| ACH | 23,026 | NEW |
| Rain Oncology Inc. | 22,370 | NEW |
Top Reduces (Value $000, Stocks/ETFs)
| GILD | -94,851 | -100.0% |
| BIIB | -88,110 | -100.0% |
| AERIE PHARMACEUTICALS INC | -73,456 | -100.0% |
| LUNG | -61,990 | -100.0% |
| CareMax, Inc. | -54,562 | -48.5% |
| Silk Road Medical Inc | -40,280 | -35.3% |
| CYTK | -39,395 | -100.0% |
| RVMD | -35,784 | -62.8% |
| ImmunoGen, Inc. | -34,141 | -52.0% |
| PHAT | -26,757 | -100.0% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|